KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Total Debt: 2011-2025

Historic Total Debt for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to $1.1 billion.

  • Sarepta Therapeutics' Total Debt fell 12.74% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 12.74%. This contributed to the annual value of $1.1 billion for FY2024, which is 8.15% down from last year.
  • Latest data reveals that Sarepta Therapeutics reported Total Debt of $1.1 billion as of Q3 2025, which was down 6.00% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Total Debt ranged from a high of $1.5 billion in Q4 2022 and a low of $1.1 billion during Q3 2025.
  • Moreover, its 3-year median value for Total Debt was $1.2 billion (2024), whereas its average is $1.2 billion.
  • Per our database at Business Quant, Sarepta Therapeutics' Total Debt skyrocketed by 58.60% in 2021 and then declined by 19.84% in 2023.
  • Quarterly analysis of 5 years shows Sarepta Therapeutics' Total Debt stood at $1.1 billion in 2021, then skyrocketed by 40.79% to $1.5 billion in 2022, then fell by 19.83% to $1.2 billion in 2023, then declined by 8.15% to $1.1 billion in 2024, then decreased by 12.74% to $1.1 billion in 2025.
  • Its Total Debt was $1.1 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.1 billion in Q1 2025.